|
Issue |
Title |
|
No 6 (2025) |
Comparative evaluation of skin wound healing depending on the type of medication correction of experimental hypogonadism in male rats |
Abstract
PDF (Rus)
|
S. V. Aysaeva, V. V. Salukhov, E. V. Kryukov, S. E. Rusakova, I. A. Odintsova, A. A. Khovpachev, V. A. Basharin, A. A. Minakov |
|
No 6 (2025) |
Evaluation of the effectiveness of the AMS questionnaire for screening hypogonadism in men with ankylosing spondylitis |
Abstract
PDF (Rus)
|
T. S. Panevin, Sh. F. Erdes, E. G. Zotkin, S. I. Glukhova, E. P. Salyanova, E. Yu. Samarkina |
|
No 6 (2025) |
Beyond BMI: We are discussing a new concept for the definition and diagnosis of clinical obesity |
Abstract
PDF (Rus)
|
T. Yu. Demidova, O. A. Kislyak, A. V. Starodubova, I. G. Nikitin, F. O. Ushanova |
|
No 6 (2025) |
A search for predictors of low-energy fractures in patients with primary hyperparathyroidism after parathyroidectomy |
Abstract
PDF (Rus)
|
A. P. Pershina-Miliutina, A. K. Eremkina, I. D. Ozhimalov, A. M. Gorbacheva, N. G. Mokrysheva |
|
No 6 (2025) |
Addressing acromegaly and its musculoskeletal complications through new treatment strategies: Focus on growth hormone antagonists |
Abstract
PDF (Rus)
|
N. V. Vorokhobina, S. N. Fogt, A. V. Kuznetsova, K. A. Balandina, R. K. Galakhova |
|
No 16 (2024) |
The role and function of metformin in women’s reproductive health: From pre-pregnancy preparation to breastfeeding |
Abstract
PDF (Rus)
|
T. Yu. Demidova, A. S. Teplova, E. V. Stepanova |
|
No 16 (2024) |
Primary hyperparathyroidism with intrathyroidal location of parathyroid adenoma |
Abstract
PDF (Rus)
|
M. I. Fadeeva, L. Z. Vasifova, E. A. Savelyeva, L. S. Urusova, A. K. Eremkina, N. G. Mokrysheva |
|
No 16 (2024) |
Regional and ethnic factors of obesity and diabetes mellitus in women of re-productive age in the Pribaikal region |
Abstract
PDF (Rus)
|
T. V. Egorova, V. V. Kireeva, L. Yu. Khamnueva |
|
No 16 (2024) |
Application of liquid chromatography-mass spectrometry for the determination of semaglutide in human serum in clinical pharmacokinetic studies |
Abstract
PDF (Rus)
|
P. K. Karnakova, Е. S. Vetrova, P. A. Karpova, A. E. Knyazeva, O. A. Archakova, N. S. Bagaeva, A. N. Arefeva, V. V. Banko, I. E. Makarenko, T. N. Komarov, I. E. Shohin |
|
No 16 (2024) |
The place of pasireotide in precision treatment of patients with acromegaly |
Abstract
PDF (Rus)
|
E. V. Pronin, T. M. Alexeeva, V. S. Pronin, M. B. Antsiferov |
|
No 16 (2024) |
Clinical and epidemiological characteristics of patients with pheochromocytoma and retroperitoneal paraganglioma |
Abstract
PDF (Rus)
|
D. V. Rebrova, N. V. Vorokhobina |
|
No 16 (2024) |
Semaglutide for the treatment of obesity: Results of two open randomized pharmacokinetic studies |
Abstract
PDF (Rus)
|
S. M. Noskov, A. N. Arefeva, V. V. Banko, К. S. Radaeva, M. L. Gefen, O. A. Archakova, P. K. Karnakova, E. S. Vetrova, P. A. Karpova, T. N. Komarov, I. E. Shohin |
|
No 6 (2024) |
Predictors of morphofunctional features of somatotrophic tumors and of the effectiveness of treatment with first-generation somatostatin receptor ligands |
Abstract
PDF (Rus)
|
E. V. Pronin, V. S. Pronin, M. B. Antsiferov, A. V. Petryaykin, T. M. Alexeeva, A. M. Lapshina, L. S. Urusova, A. N. Khoruzhaya, S. M. Tamaeva |
|
No 6 (2024) |
Functional hypogonadism in men: key causes and neuroendocrine mechanisms of its development |
Abstract
PDF (Rus)
PDF (Eng)
|
V. V. Salukhov, S. V. Aisaeva |
|
No 6 (2024) |
Phenylpiracetam: molecular mechanisms of effects in obesity |
Abstract
PDF (Rus)
|
O. A. Gromova, I. Yu. Torshin, L. B. Lazebnik |
|
No 6 (2024) |
Antenatal dexamethasone treatment and long-term programming |
Abstract
PDF (Rus)
|
A. V. Shaitarova, L. A. Suplotova |
|
No 6 (2024) |
New aspects in the diagnosis and treatment of polycystic ovary syndrome |
Abstract
PDF (Rus)
|
V. V. Efimenko, M. V. Khachaturov, A. M. Gasanova, N. S. Martirosian, I. A. Kuzina, E. V. Goncharova, M. E. Telnova, N. A. Petunina |
|
No 6 (2024) |
Endocrinological aspects of gout |
Abstract
PDF (Rus)
|
T. S. Panevin, E. N. Kareva |
|
No 9 (2023) |
Influence of zoledronic acid therapy on long-term results of medical rehabilitation of patients with osteoporotic vertebral fracrures |
Abstract
PDF (Rus)
|
L. A. Marchenkova |
|
No 9 (2023) |
Effects of various weight-reducing drugs on eating behavior |
Abstract
PDF (Rus)
|
G. G. Zasypkin, T. I. Golikova, G. A. Matveev, A. Yu. Babenko |
|
No 9 (2023) |
Mechanisms of thyroid hypofunction influence on the formation of the cardiovascular system pathology |
Abstract
PDF (Rus)
|
O. M. Uryasev, S. V. Berstneva, S. I. Glotov, P. L. Demina |
|
No 9 (2023) |
Osteosarcopenia as a satellite of aging |
Abstract
PDF (Rus)
|
B. I. Isaeva, K. M. Alieva-Kharkharova |
|
No 9 (2023) |
Cardiovascular pathology and intestinal microbiome relationship: potential targets of pharmacotherapy |
Abstract
PDF (Rus)
|
Y. A. Sorokina, N. A. Petunina, S. D. Sinyushkina, A. V. Gorinova, M. I. Pryazhnikova, S. A. Sukhanov, A. S. Rudakov, O. V. Zanozina |
|
No 10 (2022) |
Efficacy of sibutramine in different types of eating behavior in obese patients |
Abstract
PDF (Rus)
|
G. A. Matveev, A. Yu. Babenko |
|
No 10 (2022) |
Octreotide in the treatment of acromegaly – the possibilities of high-dose therapy |
Abstract
PDF (Rus)
|
I. A. Ilovayskaya |
|
No 10 (2022) |
Antenatal glucocorticosteroids treatment: mechanisms of child healths programming |
Abstract
PDF (Rus)
|
A. V. Shaitarova, L. A. Suplotova |
|
No 10 (2022) |
Replacement of prolonged-acting octreotide with lanreotide autogel 120 mg in patients with Acromegaly in real clinical practice |
Abstract
PDF (Rus)
|
U. A. Tsoy, E. N. Kravchuk, A. B. Dalmatova, L. V. Belousova, E. N. Grineva |
|
No 10 (2022) |
Features of the intestinal microbiome in patients with thyroid diseases |
Abstract
PDF (Rus)
|
M. V. Solovev, K. P. Raevskiy, A. N. Sorokin |
|
No 10 (2022) |
Selective vitamin D receptor activator Paricalcitol and its potential benefits in hemodialysis patients with secondary hyperparathyroidism |
Abstract
PDF (Rus)
|
L. V. Egshatyan |
|
No 7 (2021) |
Qualification in the field of osteoporosis treatment in doctors working in the field of physical and rehabilitation medicine |
Abstract
PDF (Rus)
|
L. A. Marchenkova |
|
No 7 (2021) |
Bone remodeling markers and their role in oncology |
Abstract
PDF (Rus)
|
O. O. Golounina, Zh. E. Belaya |
|
No 7 (2021) |
Analysis of risk factors for vitamin D deficiency by results of the first stage of Russian non-interventional register study |
Abstract
PDF (Rus)
|
L. A. Suplotova, V. A. Avdeeva, L. Y. Rozhinskaya, E. A. Pigarova, E. A. Troshina |
|
No 7 (2021) |
Effect of liraglutide 3.0 mg on eating behavior in patients with obesity |
Abstract
PDF (Rus)
|
O. V. Logvinova, E. A. Troshina |
|
No 7 (2021) |
Clinical observation of a patient with TMEM127 and EGLN1 gene variants, pheochromocytoma and pancreatic tumor |
Abstract
PDF (Rus)
|
M. Yu. Yukina, V. R. Mustafina, E. V. Vasilyev, E. A. Troshina, N. M. Platonova, D. G. Beltsevich |
|
No 7 (2021) |
Riedel's thyroiditis: diagnostic difficulties (clinical case and brief review) |
Abstract
PDF (Rus)
|
A. A. Rybakova, N. M. Platonova, T. V. Soldatova, N. V. Tarbaeva, T. S. Panevin, E. A. Troshina |
|
No 7 (2021) |
Adherence to somatostatin analog therapy for acromegaly |
Abstract
PDF (Rus)
|
I. A. Ilovayskaya |
|
No 7 (2020) |
Hypothyroidism: current state of the problem |
Abstract
PDF (Rus)
|
E. V. Biryukova, D. V. Kileynikov, I. V. Solovyeva |
|
No 7 (2020) |
Obesity: The Crossroads of Opinion, Knowledge, and Opportunity |
Abstract
PDF (Rus)
|
L. A. Ruyatkina, D. S. Ruyatkin |
|
No 7 (2020) |
Oral bisphosphonates as the therapy of choice in patients with moderate risk of fractures |
Abstract
PDF (Rus)
|
L. A. Marchenkova, E. V. Makarova |
|
No 7 (2020) |
Clinical case of factitious hypoglycemia |
Abstract
PDF (Rus)
|
M. Yu. Yukina, N. F. Nuralieva, E. A. Troshina, V. A. Ioutsi |
|
No 7 (2020) |
New opportunities for secondary drug therapy of acromegaly |
Abstract
PDF (Rus)
|
V. S. Pronin, E. V. Pronin |
|
No 4 (2019) |
Possibilities to assess insulin resistance as the metabolic syndrome is clustered in women in postmenopause |
Abstract
PDF (Rus)
|
L. A. Ruyatkina, D. S. Ruyatkin, I. S. Iskhakova, L. V. Scherbakova |
|
No 4 (2019) |
Obesity as an oncological risk factor. Literature review |
Abstract
PDF (Rus)
|
V. V. Salukhov, D. V. Kadin |
|
No 4 (2019) |
Fat tissue and adrenal function: mechanisms of mutual influence |
Abstract
PDF (Rus)
|
N. V. Mazurina, E. V. Ershova, E. A. Troshina, E. S. Senyushkina, A. N. Tyulpakov, V. A. Ioutsi |
|
No 4 (2019) |
Musculoskeletal system pathology: focus on sarcopenia and osteosarcopenia |
Abstract
PDF (Rus)
|
N. V. Toroptsova, A. Yu. Feklistov |
|
No 4 (2018) |
Genetically determined causes of hypoglycemic syndrome in adults without diabetes |
Abstract
PDF (Rus)
|
M. Yu. Yukina, N. F. Nuralieva, E. A. Troshina, N. M. Platonova, N. S. Kuznetsov |
|
No 4 (2018) |
Issues of differential diagnosis and management of central diabetes insipidus / differential diagnosis and management of central diabetes insipidus |
Abstract
PDF (Rus)
|
G. R. Vagapova |
|
No 4 (2018) |
Obesity: a contemporary world issue. An overview of possible therapeutic approaches to therapy |
Abstract
PDF (Rus)
|
A. M. Mkrtumyan |
|
No 4 (2018) |
Efficacy of liraglutide 3 mig therapy in obesity and associated diseases |
Abstract
PDF (Rus)
|
K. A. Komshilova, E. A. Troshina |
|
No 4 (2018) |
Osteal and extraosteal effects of vitamin D and its opportunities of medication correction of its deficiency |
Abstract
PDF (Rus)
|
V. V. Salukhov, E. A. Kovalevskaya, V. V. Kurbanova |
|
No 4 (2018) |
Clinical and functional features of thyroid gland dysfunction combined with metabolic syndrome |
Abstract
PDF (Rus)
|
A. A. Fateevа, N. A. Martirosyan, N. A. Petunina |
|
No 3 (2017) |
SECONDARY HYPOTHYROIDISM: CURRENT APPROACHES TO DIAGNOSIS AND TREATMENT |
Abstract
PDF (Rus)
|
T. A. Gavrilova, T. B. Morgunova, V. V. Fadeev |
|
No 3 (2017) |
ORLISTAT IN COMBINATION THERAPY OF OBESITY AND TYPE 2 DIABETES |
Abstract
PDF (Rus)
|
A. M. Mkrtumyan, E. V. Biryukova |
|
No 3 (2017) |
CURRENT VIEWS ON THE TREATMENT OF ACROMEGALY WITH SOMATOSTATIN ANALOGUES |
Abstract
PDF (Rus)
|
I. A. Ilovaiskaya |
|
No 3 (2017) |
CLINICAL FOLLOW-UP OF A PATIENT WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM DURING TREATMENT WITH SIBUTRAMINE AND LEVOTHYROXINE SODIUM |
Abstract
PDF (Rus)
|
E. A. Troshina, M. O. Galieva, M. S. Mikhina, N. V. Mazurina |
|
No 3 (2017) |
RESULTS OF A 20-YEAR FOLLOW-UP OF CHILDREN WITH GROWTH HORMONE DEFICIENCY IN THE REPUBLIC OF TATARSTAN |
Abstract
PDF (Rus)
|
L. M. Sultanova, O. G. Pecheritsa, N. V. Krinitskaya |
|
No 3 (2017) |
DIABETES INSIPIDUS AND COMORBID VIOLATIONS OF FLUID-SALT BALANCE |
Abstract
PDF (Rus)
|
V. S. Lukyanchikov |
|
No 3 (2017) |
EARLY EXPERIENCE OF GPP-1 LIRAGLUTIDE 3.0 MG ANALOGUE IN RUSSIA AND ITS EFFECT ON METABOLIC RISK FACTORS IN OBESITY PATIENTS |
Abstract
PDF (Rus)
|
K. A. Komshilova, E. A. Troshina, E. V. Ershova, O. V. Logvinova |
|
No 3 (2016) |
Men's health in type 2 diabetes. Focus on metabolic and antioxidant properties of testosterone |
Abstract
PDF (Rus)
|
А. S. Ametov , L. L. Kamynina , O. A. Rozhdestvenskaya , E. Y. Pashkova |
|
No 3 (2016) |
Obesity: current approaches to adequate pharmacotherapy |
Abstract
PDF (Rus)
|
M. L. Maksimov, S. S. Sologova, O. V. Dralova |
|
No 3 (2016) |
Hypothyroidism: current diagnostic and treatment principles |
Abstract
PDF (Rus)
|
T. B. Morgunova, V. V. Fadeev |
|
No 3 (2016) |
Current aspects of prevention and treatment of iodine deficiency disorders. Focus on risk groups |
Abstract
PDF (Rus)
|
E. A. Troshina |
|
No 3 (2016) |
Principles of diagnosis and treatment of nodular goiter |
Abstract
PDF (Rus)
|
T. Y. Demidova , I. N. Drozdova , N. P. Potekhin , F. A. Orlov |
|
1 - 63 of 63 Items |
|